Frequency of homologous recombination deficiency gene mutations in melanoma and its relevance to the immunotherapeutic response.

被引：2
|
作者：
Liu, Huanhuan [1 ]
Zhang, Yanrui [1 ]
Ding, Feng [1 ]
Zhang, Yun [1 ]
Liang, Xiayuan [1 ]
Lou, Feng [1 ]
Cao, Shanbo [1 ]
Wang, Huina [1 ]
机构：
[1] AcornMed Biotechnol Co Ltd, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e15073
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15073
引用
收藏
页数：4
相关论文
共 50 条
  • [11] Are Homologous Recombination Deficiency Mutations Relevant in Colorectal Cancer?
    Lee, Michael S.
    Kopetz, Scott
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (02): : 176 - 178
  • [12] Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic Approach
    Kim, Kevin B.
    Soroceanu, Liliana
    de Semir, David
    Millis, Sherri Z.
    Ross, Jeffrey
    Vosoughi, Elham
    Dar, Altaf A.
    Nosrati, Mehdi
    Desprez, Pierre-Yves
    Ice, Ryan
    Chen, Michelle
    Chetal, Kashish
    Bhattacharjee, Anukana
    Moretto, John
    Leong, Stanley P.
    Singer, Mark, I
    Parrett, Brian M.
    Minor, David R.
    McAllister, Sean
    Miller, James R., III
    Salomonis, Nathan
    Kashani-Sabet, Mohammed
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (08) : 2028 - +
  • [13] Phase II study of niraparib in patients with advanced melanoma with homologous recombination pathway gene mutations
    Kim, K. B.
    Desprez, P.
    Caressi, C.
    Nosrati, M.
    Janiczek, E.
    Penafiel, J.
    Kashani-Sabet, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S719 - S720
  • [14] Deciphering the role of homologous recombination deficiency mutations in the response to combined immune checkpoint and PARP inhibitors
    Chaudhuri, Sibapriya
    Thomas, Scott
    Timmerman, Luika
    Munster, Pamela
    CANCER RESEARCH, 2024, 84 (03)
  • [15] Modification of an endogenous gene by homologous recombination: Frequency and recombination processes of gene targeting
    Johzuka-Hisatomi, Yasuyo
    Terada, Rie
    Iida, Shigeru
    GENES & GENETIC SYSTEMS, 2006, 81 (06) : 411 - 411
  • [16] Homologous Recombination Deficiency and Tumor Mutational Burden as Clinical Biomarkers for Melanoma
    Yip, J.
    Lum, C.
    Halford, Z.
    Pon, J.
    Woron, A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 158 (SUPP 1) : S144 - S145
  • [17] A Systematic Review and Meta-Analysis on the Prognostic Value of BRCA Mutations, Homologous Recombination Gene Mutations, and Homologous Recombination Deficiencies in Cancer
    Shao, Changxia
    Chang, Michael S.
    Lam, Fred C.
    Marley, Andrew R.
    Tang, Huilin
    Song, Yiqing
    Miller, Chelsey
    Brown, Madeline
    Wan, Isabella
    Han, Jiali
    Adeboyeje, Gboyega
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [18] Frequency of homologous recombination-related gene mutations in breast cancer and their correlation with tumor mutation burden
    Lan, Haitao
    Bu, Qing
    Zhuang, Li
    Ren, Shuang
    Yan, Xuexin
    Li, Ye
    Yu, Qian
    Shi, Xiaoliang
    Zhao, Juan
    Guo, Honglin
    Zhao, Liang
    CANCER RESEARCH, 2020, 80 (16)
  • [19] A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations
    Vogel, Anne
    Haupts, Anna
    Kloth, Michael
    Roth, Wilfried
    Hartmann, Nils
    DIAGNOSTIC PATHOLOGY, 2024, 19 (01)
  • [20] A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations
    Anne Vogel
    Anna Haupts
    Michael Kloth
    Wilfried Roth
    Nils Hartmann
    Diagnostic Pathology, 19
12345